Viewing StudyNCT00087711



Ignite Creation Date: 2024-05-05 @ 11:35 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00087711
Status: COMPLETED
Last Update Posted: 2019-09-12
First Post: 2004-07-12

Brief Title: A Randomized Phase 3 Trial of Pemetrexed and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer
Sponsor: Eli Lilly and Company
Organization: Eli Lilly and Company

Key Dates - Follows AllAPIJSON File Order

Start Date: 2004-07
Start Date Type: None
Primary Completion Date: 2007-01
Primary Completion Date Type: ACTUAL
Completion Date: 2008-03
Completion Date Type: ACTUAL
First Submit Date: 2004-07-12
First Submit QC Date: July 15 2004
Study First Post Date: 2004-07-16
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2019-09-10
Last Update Post Date: 2019-09-12
Last Update Post Date Type: ACTUAL